# Shilpy Singh

Shilpy Singh works in the pharmaceutical industry, speaks about AI in pharma, and designs learning programs that connect industry teams with students and young changemakers.

- Profile: https://b2binfluencer.marketing/creators/shilpy-singh/
- LinkedIn: https://www.linkedin.com/in/shilpy-singh-108091b
- Topics: artificial-intelligence
- Based on 13 dated posts, latest 2026-09-04

## Summary

Shilpy Singh is most useful for invited talks and learning programs on AI in pharma and industry-academia connections.

- Best for: Pharmaceutical makers and event hosts needing a speaker or program collaborator for AI in pharma.
- Not for: Sponsored social campaigns with paid deliverables, audience demographics, and reach or engagement guarantees.
- Check first: Confirm capacity, internal support, references, fee, length, audience size, and availability before booking.

### Takeaways

- AI is already changing pharmaceutical work.
- Pharmaceutical knowledge is best learned on the shop floor.
- Industry should build real bridges to universities and social-sector programmes.

## Main ideas

- **AI is already changing pharmaceutical work**: Singh treats AI as a present-tense shift, tying it to outcomes: faster drug discovery, better manufacturing, more personalised care, and more equitable and sustainable healthcare. The focus is on what the technology changes in practice, making this a practical, industry-facing conversation rather than a general explainer about AI.
- **Pharmaceutical knowledge is best learned on the shop floor**: Singh designs multi-day programmes that put learners inside a working plant, with the value in seeing how functions connect and taking part in activities such as mock interviews and structured reflection. The learners’ curiosity and questions drive the learning.
- **Industry should build real bridges to universities and social-sector programmes**: Singh builds partnerships through invitations: a university society invites the company, a foundation supplies the fellows, and Singh designs the programme and collaboration between the two organisations. Students gain industry exposure and career pathways, while the company gains a channel for social impact and future talent.
- **Commercial success and public good belong in the same sentence**: Singh anchors pharmaceutical work in a stated ethos, bringing business results and service together. Patient centricity, sustainability, “doing well and doing good” and nation building recur across the manufacturing talks and fellowship programmes.
- **Inclusion is a leadership responsibility, shown in who is in the room**: Singh’s writing on inclusion focuses on visible participation and accountability: women from several functions attending together, and senior leaders credited with creating the conditions. The argument is that resilience and sustained success depend on a culture where women can learn, lead and make an impact, set from the top.

## Work to read

- [Expert talk on AI in the pharmaceutical industry](https://www.linkedin.com/posts/shilpy-singh-108091b_expert-talk-on-ai-in-the-pharmaceutical-industry-activity-7312806878009352192-ZPMD)
- [World Health Congress 2026 virtual expert panel](https://www.linkedin.com/posts/shilpy-singh-108091b_world-ai-pharma-activity-7438908548123877376-n0_R)
- [IIT Madras session on CDMO, manufacturing and sustainability](https://www.linkedin.com/posts/shilpy-singh-108091b_an-incredible-experience-at-iit-indian-activity-7307450136203268098-CjB4)
- [Three-day Gandhi Fellow induction at Pithampur, April 2025](https://www.linkedin.com/posts/shilpy-singh-108091b_empowering-gandhi-fellowyoung-changemakers-activity-7322319971487756289-ZCdk)
- [Hosting the 18th batch of Gandhi Fellows at Pithampur](https://www.linkedin.com/posts/shilpy-singh-108091b_strengthening-the-bridge-between-industry-activity-7385375127464562688-IlQf)

## Brand relationships

- **Piramal Pharma Ltd** (employment)
- **Piramal Foundation** (disclosed_partnership)
- **Chameli Devi Group of Institutions** (mention)
- **IIT Madras** (mention)
- **World Health Congress** (mention)

## Partnerships

Shilpy Singh's posts show invited engagements including conference sessions, expert panels, guest lectures for students, and multi-day training programs they delivered or designed and coordinated inside Piramal Pharma. For brands, universities or event organisers seeking a speaker or program lead on AI in pharma and industry-academia training, the realistic fit is invitation-based speaking or program design. The host carries much of the operational burden: engagements relied on an existing event or institution issuing the invitation and colleagues across functions giving their time. Ask about fees, audience size, format length and availability; Shilpy Singh's LinkedIn profile is the only contact route the posts point to.

## Alternatives

- Matt Tyson: Consider Matt Tyson if the brief shifts from an AI-in-pharma talk to pharmaceutical manufacturing and African health-system capacity. In a post about a China–Africa trip, Tyson describes meetings with pharmaceutical manufacturers and a factory visit, then argues for local production and supply-chain partnerships. That gives buyers concrete material for a discussion of manufacturing capacity and industry collaboration.
- Yvonne Pilon: Consider Yvonne Pilon if the training element matters more than pharmaceutical subject expertise. Her post about judging the University of Windsor Innovation Fellowship describes fellows exploring market validation, intellectual property and commercialization across fields including AI and medical imaging. A separate post presents cybersecurity as an accessible, human issue and points startups toward a regional support initiative. These examples suit a program about helping emerging innovators connect ideas with practical support.
- Raghuram Krishnan: Consider Raghuram Krishnan if the event is specifically for finance leaders and needs an AI-and-enterprise-transformation perspective. A post attributed to Krishnan frames the CFO as a strategic leader in data-driven decisions, technology and risk; another describes board-governance learning centered on practical cases and judgment. These examples offer a finance and governance lens on organizational change.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/